You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cyclin-dependent kinase (CDK) inhibitors

Showing 1 - 25 of 9,816
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

Not yet recruiting
  • Metastatic Breast Cancer
  • +4 more
  • CDK 4/6 inhibitors
  • Endocrine therapy
  • Helsinki, Finland
  • +11 more
Sep 19, 2023

Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

Recruiting
  • Breast Cancer
  • CT scans
  • DEXA scan
  • Bronx, New York
    Montefiore Medical Center
Jan 6, 2023

Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

Recruiting
  • Neurofibromatosis 1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

Recruiting
  • Breast Cancer Stage IV
  • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
  • Mansoura, Dakahlia, Egypt
    Oncology center mansoura university
Jan 1, 2023

Toxicity Data in Advanced Breast Cancer Treated With CDK

Completed
  • Breast Cancer Stage IV
    • Athens, Greece
      Hellenic Oncology Cooperative Group
    Feb 11, 2021

    Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

    Recruiting
    • Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
    • No intervention; observational
    • Norcross, Georgia
      Center for Rare Neurological Diseases
    Oct 20, 2022

    Breast Cancer Trial in Baltimore (Endocrine Therapy and a CDK 4/6 inhibitor)

    Recruiting
    • Breast Cancer
    • Endocrine Therapy and a CDK 4/6 inhibitor
    • Baltimore, Maryland
      Johns Hopkins University
    Jul 18, 2022

    Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

    Not yet recruiting
    • Preterm Labor
      • (no location specified)
      May 9, 2023

      Breast Cancer Trial (Chidamide+ Fulvestrant)

      Not yet recruiting
      • Breast Cancer
      • Chidamide+ Fulvestrant
      • (no location specified)
      Jan 13, 2022

      Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

      Not yet recruiting
      • Breast Cancer
      • +3 more
      • Miami, Florida
        University of Miami
      Apr 12, 2023

      Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

      Recruiting
      • Chondrosarcoma
      • +2 more
      • Jacksonville, Florida
      • +3 more
      Apr 4, 2022

      Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • (no location specified)
      May 22, 2023

      Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +2 more
      • CDK Inhibitor AT7519
      • +3 more
      • Washington, District of Columbia
      • +5 more
      Oct 18, 2022

      Cancer Trial in Boston (CYC065)

      Active, not recruiting
      • Cancer
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Apr 22, 2022

      Personalised Disease Monitoring in Metastatic Breast Cancer

      Recruiting
      • Breast Cancer Metastatic
      • Estrogen Receptor-positive Breast Cancer
        • Gothenburg, Sweden
        • +6 more
        Dec 7, 2022

        Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

        Completed
        Has Results
        • Breast Cancer
        • +2 more
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Jan 13, 2022

        CDKL5 Disorder Trial (Ganaxolone)

        Available
        • CDKL5 Disorder
        • (no location specified)
        Apr 1, 2022

        Triple Negative Breast Tumors Trial in Poland (Palbociclib, Paclitaxel, Carboplatin)

        Not yet recruiting
        • Triple Negative Breast Neoplasms
        • Wrocław, Dolnośląskie, Poland
        • +5 more
        Oct 4, 2021

        Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)

        Active, not recruiting
        Has Results
        • Advanced Breast Cancer
        • Beijing, Beijing, China
        • +6 more
        Jun 23, 2022

        Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

        Not yet recruiting
        • Solid Tumors
        • (no location specified)
        May 17, 2023

        Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

        Not yet recruiting
        • Advanced Breast Cancer
        • +6 more
        • Providence, Rhode Island
          Lifespan Cancer Institute
        Feb 1, 2023

        Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)

        Active, not recruiting
        • Metastatic Breast Cancer
        • Breast Carcinoma
        • Birmingham, Alabama
        • +12 more
        Feb 17, 2022

        Metastatic Breast Cancer, Breast Cancer Stage IV Trial in São Paulo

        Recruiting
        • Metastatic Breast Cancer
        • Breast Cancer Stage IV
          • São Paulo, SP, Brazil
            Hcor
          Sep 26, 2022